CRISPR-Scanning Towards New Drugs — drug discovery is difficult, but CRISPR might be able to help

by Michael Vinyard figures by┬áNicholas Lue Most therapeutic drug candidates that are put through clinical trials fail. Given that most of these fail during early development, the cost of bringing a single drug to market is now over $2.5 billion. If we focus on cancer alone, this high cost of drug development, combined with the fact that cancer is one of the leading killers in … Continue reading CRISPR-Scanning Towards New Drugs — drug discovery is difficult, but CRISPR might be able to help